Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $112,443 - $137,049
498 Added 436.84%
612 $147,000
Q4 2022

Jan 25, 2023

BUY
$229.03 - $291.01 $916 - $1,164
4 Added 3.64%
114 $30,000
Q2 2022

Jul 28, 2022

SELL
$230.71 - $256.74 $9,228 - $10,269
-40 Reduced 26.67%
110 $27,000
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $8,770 - $9,702
-40 Reduced 21.05%
150 $36,000
Q3 2021

Nov 09, 2021

SELL
$212.27 - $248.7 $315,857 - $370,065
-1,488 Reduced 88.68%
190 $40,000
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $296,179 - $328,589
1,268 Added 309.27%
1,678 $409,000
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $13,092 - $15,257
-59 Reduced 12.58%
410 $102,000
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $46,305 - $55,141
214 Added 83.92%
469 $108,000
Q3 2020

Nov 04, 2020

BUY
$234.65 - $260.95 $17,364 - $19,310
74 Added 40.88%
255 $65,000
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $1,186 - $1,456
6 Added 3.43%
181 $43,000
Q4 2019

Jan 28, 2020

BUY
$189.21 - $243.2 $33,111 - $42,560
175 New
175 $42,000
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $13,580 - $16,272
-78 Closed
0 $0
Q2 2019

Jul 19, 2019

SELL
$166.7 - $195.41 $75,681 - $88,716
-454 Reduced 85.34%
78 $14,000
Q1 2019

Apr 08, 2019

BUY
$180.87 - $203.88 $95,318 - $107,444
527 Added 10540.0%
532 $101,000
Q4 2018

Jan 18, 2019

SELL
$178.4 - $208.25 $32,290 - $37,693
-181 Reduced 97.31%
5 $1,000
Q3 2018

Oct 30, 2018

BUY
$185.29 - $208.89 $34,463 - $38,853
186 New
186 $39,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sageworth Trust CO Portfolio

Follow Sageworth Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO with notifications on news.